1 / 3UV Pharma Series — Purified & Ultrapure Water
TOC reduction and bioburden control UV systems for pharma purified water — USP, EP, WHO GMP compliant
UV Pharma Series by Ozone India Technology, Ghaziabad. Dual-wavelength 185nm+254nm UV for TOC reduction and bioburden control in pharma purified water. SS316L EP-polished reactor. USP/EP/WHO GMP compliant. CE certified.
Dual-wavelength UV systems (185nm + 254nm) purpose-built for pharmaceutical purified water loops, WFI systems, and CIP water. 185nm radiation destroys TOC (Total Organic Carbon) by photooxidation; 254nm provides bioburden control. SS316L electropolished reactor with orbital-welded connections meets USP <1231>, EP, and WHO GMP requirements. Validation documentation package available (IQ/OQ/PQ).
| UV Wavelengths | 185 nm (TOC reduction) + 254 nm (bioburden) |
|---|---|
| Flow Rate | 100 LPH to 10,000 LPH |
| TOC Reduction | From <500 ppb to <10 ppb at rated flow |
| Log Reduction | 6-log (99.9999%) bioburden control |
| Reactor Material | SS316L, EP-polished, Ra <0.4 μm |
| Connections | Tri-clamp sanitary / orbital-welded |
| Quartz | High-purity synthetic fused silica |
| UV Monitor | Online sensor, FDA 21 CFR Part 11 ready |
| Lamp Life | 9000 hours |
| Compliance | USP <1231>, EP 0169, WHO GMP, CE |
- 185 nm + 254 nm dual wavelength — TOC reduction AND bioburden control in one unit
- SS316L EP-polished Ra <0.4 μm — zero dead legs, fully drainable
- Tri-clamp / orbital-welded connections — no contamination risk
- 6-log (99.9999%) bioburden reduction — exceeds USP and EP requirements
- TOC from <500 ppb to <10 ppb — single pass at rated flow
- IQ/OQ/PQ validation documentation available
- FDA 21 CFR Part 11 compatible UV intensity data logging
- CE certified, WHO GMP compliant
INDUSTRY APPLICATIONS
Where UV Pharma Series is Used
Related Products
Request Quote or Information
UV Pharma Series
WhatsApp Us Nowor call us directly
✉️ Email EnquiryFree consultation · Pan-India delivery · 12 month warranty